Denali Therapeutics, Inc. (DNLI)
19.63
+0.22
(+1.13%)
USD |
NASDAQ |
Apr 08, 16:00
19.63
0.00 (0.00%)
After-Hours: 18:31
Denali Therapeutics Total Liabilities (Quarterly) : 131.09M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Protalix Biotherapeutics, Inc. | 34.12M |
| Agenus, Inc. | 504.66M |
| Curis, Inc. | 15.02M |
| Plus Therapeutics, Inc. | 12.33M |
| Windtree Therapeutics, Inc. | 27.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.145B |
| Shareholders Equity (Quarterly) | 1.014B |
| Debt to Equity Ratio | 0.0417 |
| Current Ratio | 9.158 |
| Net Debt Paydown Yield | 0.08% |